Clinical Trial 45843

New Port Richey, FL 34652


Summary:

Randomized, double-blind, double-dummy, placebo-controlled study, approximately 675 eligible subjects with type 2 diabetes and inadequate control on at least one and up to 3 oral glucose-lowering agents will undergo an initial 21-day Screening Period, followed by a 26-week Double-Blind Treatment Period and a 26-week Double-Blind Treatment Extension Period.


Qualified Participants Must:

• Ages Eligible for Study: 18 Years to 75 Years
• Established diagnosis of T2DM for at least 6 months


Qualified Participants May Receive:

Intervention/treatment: Placebo, ORMD-0801 QD, or ORMD-0801 BD

Compensation for time and travel.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.